Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Saskatchewan

$27,000.00

Investigating Acute Intermittent Hypoxia as a Novel Non-Invasive Therapy for Rapid Sensitization of Neural Tissue to the Repair-Promoting Neurotrophin Nerve Growth Factor

EF 2025-26

Résumé
When peripheral nerves are injured, creating an enhanced robust repair response prevents loss of function and chronic pain states, particularly when regeneration distances are lengthy. The Verge lab has shown that a novel non-invasive therapy, Acute Intermittent Hypoxia [AIH; brief cycles of normal (21%) and low oxygen (11%)] enhances peripheral nerve regeneration, but many of the underlying neuronal mechanisms remain unknown. Understanding these mechanisms is critical to determine optimal treatment schedules to bolster regenerative responses in upcoming clinical trials. Our work focuses on the prototypical neurotrophic factor Nerve Growth Factor (NGF) and it’s high-affinity receptor trkA. After injury, NGF provides guidance cues for regenerating axons, but this response is short-lived. Previous studies show that increasing neural activity through invasive methods mobilizes ~50% more trkA to the plasma membrane (PM) of sensory neurons, enhancing their sensitivity to NGF. AIH similarly increases neural activity but does so through a non-invasive, clinically feasible approach. My project will test the hypothesis that AIH treatment, delivered in vitro or in vivo, increases trkA mobilization to the PM of sensory neurons, causing an associated increased response to NGF regeneration guidance cues. Using a sciatic nerve injury model in adult male and female rats, I will assess how in vivo AIH affects PM trkA levels and axon regeneration distance. Complementary in vitro studies using primary sensory neurons will evaluate how AIH alters PM composition, how increased neural activity is involved, and responsiveness to NGF. Defining the cellular mechanisms by which AIH enhances peripheral nerve regeneration will allow treatment to be optimized and translated to clinical use.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573299
Name
Wilson Maya R
Region
Saskatchewan
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Acute Intermittent Hypoxia as a Novel Non-Invasive Therapy for Rapid Sensitization of Neural Tissue to the Repair-Promoting Neurotrophin Nerve Growth Factor
Programtype2
Studentship Programs
Orgnameinp2
University of Saskatchewan
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Acute Intermittent Hypoxia; Dorsal Root Ganglia; Nerve Growth Factor; Nerve Repair; Neurotrophins; Peripheral Nerve Regeneration; Primary Neuronal Culture; Sensory Neurons
Abstract
When peripheral nerves are injured, creating an enhanced robust repair response prevents loss of function and chronic pain states, particularly when regeneration distances are lengthy. The Verge lab has shown that a novel non-invasive therapy, Acute Intermittent Hypoxia [AIH; brief cycles of normal (21%) and low oxygen (11%)] enhances peripheral nerve regeneration, but many of the underlying neuronal mechanisms remain unknown. Understanding these mechanisms is critical to determine optimal treatment schedules to bolster regenerative responses in upcoming clinical trials. Our work focuses on the prototypical neurotrophic factor Nerve Growth Factor (NGF) and it’s high-affinity receptor trkA. After injury, NGF provides guidance cues for regenerating axons, but this response is short-lived. Previous studies show that increasing neural activity through invasive methods mobilizes ~50% more trkA to the plasma membrane (PM) of sensory neurons, enhancing their sensitivity to NGF. AIH similarly increases neural activity but does so through a non-invasive, clinically feasible approach. My project will test the hypothesis that AIH treatment, delivered in vitro or in vivo, increases trkA mobilization to the PM of sensory neurons, causing an associated increased response to NGF regeneration guidance cues. Using a sciatic nerve injury model in adult male and female rats, I will assess how in vivo AIH affects PM trkA levels and axon regeneration distance. Complementary in vitro studies using primary sensory neurons will evaluate how AIH alters PM composition, how increased neural activity is involved, and responsiveness to NGF. Defining the cellular mechanisms by which AIH enhances peripheral nerve regeneration will allow treatment to be optimized and translated to clinical use.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wilson, Maya R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~